CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.
about
Body fluid biomarkers in Alzheimer's diseaseShift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventionsBehavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.Cerebrospinal fluid and blood biomarkers in Alzheimer's diseaseA Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's DiseasePET amyloid-beta imaging in preclinical Alzheimer's diseaseUpdate on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.CSF biomarkers for mild cognitive impairment.Biomarkers in the diagnosis of Alzheimer's disease: are we ready?Biomarkers for early detection of Alzheimer pathology.The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide.Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.Biomarkers in translational research of Alzheimer's diseaseRecent cerebrospinal fluid biomarker studies of Alzheimer's disease.Differentially charged isoforms of apolipoprotein E from human blood are potential biomarkers of Alzheimer's disease.BioAge: toward a multi-determined, mechanistic account of cognitive aging.Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop.Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.Biomarkers predicting Alzheimer's disease in cognitively normal aging.CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy.Non-invasive screening for Alzheimer's disease by sensing salivary sugar using Drosophila cells expressing gustatory receptor (Gr5a) immobilized on an extended gate ion-sensitive field-effect transistor (EG-ISFET) biosensor.CSF tau and β-amyloid as biomarkers for mild cognitive impairment.Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's diseaseCombining select neuropsychological assessment with blood-based biomarkers to detect mild Alzheimer's disease: a molecular neuropsychology approach.CSF biomarkers for Alzheimer's disease: current utility and potential future use.MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseaseCerebrospinal fluid protein biomarkers for Alzheimer's disease.CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.Peptide profiling of cerebrospinal fluid by mass spectrometry.Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?Fluid biomarkers in Alzheimer's disease - current conceptsCerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer diseaseCommentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease." Biochemical biomarkers of late-life dementia.Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.Biomarkers related to aging in human populations.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.
P2860
Q26830098-43F4BA9E-2E08-4BD5-8F59-5C1FC7A34882Q26830740-D57653D4-64B2-4F9F-9E53-3B24F5969B37Q26858963-AAF4350F-DE55-404A-A55B-FE04990DDD48Q27023758-354A8290-2DB6-4424-A8E6-8CAD6D9FA3D7Q28276977-4082B719-1472-4D10-8678-98142D70A15CQ30040695-BCC10708-58B5-46F1-86CF-23611678B0F7Q30845482-2E8212DD-19A3-4A03-8812-00520543F455Q30953185-52602151-B09F-4614-BBBA-1293452EA6BCQ31050728-1C2875F5-1C1C-41A9-AAB7-4C009FE5841EQ31140680-74ABD954-BDE2-4B52-88E4-CA72FB07A482Q33187435-1A93716C-A1A5-4350-A2D4-0FBCD277DC3FQ33223171-AF72AFBB-14FA-4C70-9B68-CC61119140E3Q33556189-5E1D1F4D-9072-4CF3-83D8-B650AD82F722Q33766323-D38F0BF9-0E3F-4058-9A54-57586CC0B5FFQ34629556-5578A1A4-7935-487F-A527-42045F558D1CQ34644175-5926E775-90DF-4E62-99FE-CBFCB1810442Q34901063-E798D44C-176D-436F-8FCE-F031B33330EBQ35034130-39AF90A1-4E6F-44A2-B692-5C9E3EFDE4B9Q35076119-773B1BCF-B216-4053-B45A-A508706F7197Q35091673-EACA81E6-6AF0-4D1C-A5BD-C3E82FC85033Q35114771-3B5DBECC-89AD-490C-90E5-D1B456C60C8CQ35123008-42D66446-CB81-4032-88F5-2124195C3141Q35236838-21936B8D-56B1-45E0-BF3D-6F469DABBDDEQ35284971-CF5BA0AB-AE90-453A-9DEB-5ACFCDD65D53Q35559746-138E15D1-7C5E-47CD-BD3A-EEEAFC35823AQ35600993-5D15C01A-53ED-4E7A-9D16-79D129E98709Q35629123-56B5084D-AC78-4154-AC55-770A15AB6309Q36045282-232DA5E2-2B7A-476A-9717-C84FCB074E15Q36252166-0FC7D65D-7A8B-4687-BD11-20B03D2C9778Q36382217-A989DDD8-8D92-4ED9-B088-4D2F4E96AB18Q36505671-CC5F5314-1C4F-45A1-A8D2-E0E82C3BEF18Q36599172-B0E77739-4228-4615-9D1E-7FBE6D51821FQ36600561-5A0E8822-ABAD-4776-9AE1-E46AAD74E043Q36939128-0E817A81-08BC-425B-ADE1-688FB975FBFFQ36953503-6114986C-2627-457B-B907-F561A5AE9BDBQ37184051-9F99635D-39D1-449A-9C4B-8F84CAB189C1Q37267425-BA3CF99D-B643-45EE-9F5B-5BA488756E62Q37272348-D8421593-C446-41C2-98CD-18DC24E05E62Q37323794-90002559-CF96-421B-9F1D-00DD3E7889ABQ37358672-6E3B0FDF-B076-48EA-AFF6-774D35AFEE9A
P2860
CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@ast
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@en
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@nl
type
label
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@ast
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@en
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@nl
prefLabel
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@ast
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@en
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@nl
P921
P356
P1476
CSF total tau, Abeta42 and pho ...... rkers for Alzheimer's disease.
@en
P2093
P2888
P356
10.1385/MN:24:1-3:087
P577
2001-08-01T00:00:00Z
P6179
1019682346